Updates in Palliative Care - Overview and Recent Advancements in the Pharmacological Management of Cancer Pain

Overview

Journal Clin Med (Lond)

Specialty General Medicine

Date 2018 Feb 14

PMID 29436434

Citations 11

Authors

Helen Wood

Andrew Dickman

Angela Star

Jason W Boland

Affiliations

Soon will be listed here.

Abstract

Pain is a common symptom in many types of cancer. Interdisciplinary team management, including pain assessment, explanation to the patient/family, treating the reversible, non-pharmacological treatments and reassessment are essential. This article focuses on the pharmacological management of cancer pain, and overviews and updates on the recent advances in this field. Both non-opioid and opioid analgesia as well as coanalgesics (adjuvants) are reviewed. Within non-opioid analgesia the risks of non-steroidal anti-inflammatory drugs (NSAIDs) are considered and recommendations for NSAIDs in patients at risk of gastrointestinal and cardiovascular toxicity are made. For opioid analgesics, side effects of opioids are discussed alongside practical guidance on opioid prescribing and converting between opioids. Newer drugs such as tapentadol are considered in this update. Amitriptyline, duloxetine, gabapentin and pregabalin, and the guidance for their use are reviewed in the coanalgesics (adjuvants) section.

Citing Articles

Exploring the integration of dentistry within a multidisciplinary palliative care team: does bedside dental care improve quality of life and symptom burden in inpatient palliative care patients?.

Uhlig S, Doberschutz F, Hallmann F, Salm H, Sigle J, Pink D Support Care Cancer. 2024; 32(8):491.

PMID: 38976073 PMC: 11231016. DOI: 10.1007/s00520-024-08671-4.

Promising Effects of Casearins in Tumor-Bearing Mice and Antinociceptive Action against Oncologic Pain: Molecular Docking and In Vivo Findings.

Silva J, Filho J, Acha B, Almeida F, Batista E, Rodrigues Silva V Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794204 PMC: 11124378. DOI: 10.3390/ph17050633.

Experiences of patients with advanced cancer coping with chronic pain: a qualitative analysis.

Xia W, Ou M, Chen Y, Chen F, Yan M, Xiao Z BMC Palliat Care. 2024; 23(1):94.

PMID: 38600476 PMC: 11005139. DOI: 10.1186/s12904-024-01418-2.

Effects of Opioids on Immune and Endocrine Function in Patients with Cancer Pain.

Bradley A, Boland J Curr Treat Options Oncol. 2023; 24(7):867-879.

PMID: 37145383 PMC: 10271882. DOI: 10.1007/s11864-023-01091-2.

Moxibustion as an Adjuvant Therapy for Cancer Pain: A Systematic Review and Meta-Analysis.

Li Y, Hong E, Ye W, You J J Pain Res. 2023; 16:515-525.

PMID: 36824500 PMC: 9942498. DOI: 10.2147/JPR.S396696.

References

Boland J, Ziegler L, Boland E, McDermid K, Bennett M . Is regular systemic opioid analgesia associated with shorter survival in adult patients with cancer? A systematic literature review. Pain. 2015; 156(11):2152-2163. DOI: 10.1097/j.pain.0000000000000306. View

Laird B, McMillan D, Fayers P, Fearon K, Kaasa S, Fallon M . The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer. Oncologist. 2013; 18(9):1050-5. PMC: 3780637. DOI: 10.1634/theoncologist.2013-0120. View

Carmona-Bayonas A, Jimenez Fonseca P, Virizuela Echaburu J . Tapentadol for Cancer Pain Management: A Narrative Review. Pain Pract. 2017; 17(8):1075-1088. DOI: 10.1111/papr.12556. View

Drewes A, Jensen R, Nielsen L, Droney J, Christrup L, Arendt-Nielsen L . Differences between opioids: pharmacological, experimental, clinical and economical perspectives. Br J Clin Pharmacol. 2012; 75(1):60-78. PMC: 3555047. DOI: 10.1111/j.1365-2125.2012.04317.x. View

Mercadante S, Ferrera P, Villari P, Casuccio A, Intravaia G, Mangione S . Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage. 2009; 37(4):632-41. DOI: 10.1016/j.jpainsymman.2007.12.024. View

Roxburgh C, McMillan D . Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer. 2014; 110(6):1409-12. PMC: 3960633. DOI: 10.1038/bjc.2014.90. View

von Gunten C . The Pendulum Swings for Opioid Prescribing. J Palliat Med. 2016; 19(4):348. DOI: 10.1089/jpm.2016.0079. View

Baron R, Eberhart L, Kern K, Regner S, Rolke R, Simanski C . Tapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data. Pain Pract. 2016; 17(5):678-700. DOI: 10.1111/papr.12515. View

Star A, Boland J . Updates in palliative care - recent advancements in the pharmacological management of symptoms. Clin Med (Lond). 2018; 18(1):11-16. PMC: 6330925. DOI: 10.7861/clinmedicine.18-1-11. View

10.

Boland J, Pockley A . Influence of opioids on immune function in patients with cancer pain: from bench to bedside. Br J Pharmacol. 2017; 175(14):2726-2736. PMC: 6016628. DOI: 10.1111/bph.13903. View

11.

Mishra S, Bhatnagar S, Goyal G, Rana S, Upadhya S . A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care. 2011; 29(3):177-82. DOI: 10.1177/1049909111412539. View

12.

Boland J, Boland E . Pharmacological therapies for opioid induced constipation in adults with cancer. BMJ. 2017; 358:j3313. DOI: 10.1136/bmj.j3313. View

13.

Corli O, Floriani I, Roberto A, Montanari M, Galli F, Greco M . Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids. Ann Oncol. 2016; 27(6):1107-1115. DOI: 10.1093/annonc/mdw097. View

14.

Smith E, Pang H, Cirrincione C, Fleishman S, Paskett E, Ahles T . Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013; 309(13):1359-67. PMC: 3912515. DOI: 10.1001/jama.2013.2813. View

15.

Caraceni A, Hanks G, Kaasa S, Bennett M, Brunelli C, Cherny N . Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012; 13(2):e58-68. DOI: 10.1016/S1470-2045(12)70040-2. View

16.

Tzschentke T, Christoph T, Kogel B . The mu-opioid receptor agonist/noradrenaline reuptake inhibition (MOR-NRI) concept in analgesia: the case of tapentadol. CNS Drugs. 2014; 28(4):319-29. DOI: 10.1007/s40263-014-0151-9. View

17.

Wiffen P, Derry S, Moore R, McNicol E, Bell R, Carr D . Oral paracetamol (acetaminophen) for cancer pain. Cochrane Database Syst Rev. 2017; 7:CD012637. PMC: 6369932. DOI: 10.1002/14651858.CD012637.pub2. View

18.

Bennett M, Laird B, van Litsenburg C, Nimour M . Pregabalin for the management of neuropathic pain in adults with cancer: a systematic review of the literature. Pain Med. 2013; 14(11):1681-8. DOI: 10.1111/pme.12212. View

19.

Fine P . Treatment guidelines for the pharmacological management of pain in older persons. Pain Med. 2012; 13 Suppl 2:S57-66. DOI: 10.1111/j.1526-4637.2011.01307.x. View

20.

Kane C, Mulvey M, Wright S, Craigs C, Wright J, Bennett M . Opioids combined with antidepressants or antiepileptic drugs for cancer pain: Systematic review and meta-analysis. Palliat Med. 2017; 32(1):276-286. DOI: 10.1177/0269216317711826. View